Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort - Concepedia

Concepedia

Publication | Open Access

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort

DOI Full Paper Access

34

Citations

32

References

2017

Year

Karine Lacombe, Hélène Fontaine, Catherine Dhiver, Sophie Métivier, Eric S. Rosenthal, Térésa Antonini, Marc Antoine Valantin, Patrick Miailhes, Stanislas Harent, Dominique Batisse,

JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

DCV+SOF±RBV achieved high SVR12 and was well tolerated in this large real-world cohort of HIV/HCV coinfected patients with advanced liver disease.

References

	Year	Citations

Page 1